相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SMAD2, SMAD3 and SMAD4 Mutations in Colorectal Cancer
Nicholas I. Fleming et al.
CANCER RESEARCH (2013)
Therapeutic RNA aptamers in clinical trials
Padma Sundaram et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Four Amino Acids within a Tandem QxVx Repeat in a Predicted Extended α-Helix of the Smad-Binding Domain of Sip1 Are Necessary for Binding to Activated Smad Proteins
Andrea Conidi et al.
PLOS ONE (2013)
TGF-β signalling and its role in cancer progression and metastasis
Yvette Drabsch et al.
CANCER AND METASTASIS REVIEWS (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects
Francisco J. Lopez-Hernandez et al.
CELL AND TISSUE RESEARCH (2012)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
BMP signaling in vascular diseases
Jie Cai et al.
FEBS LETTERS (2012)
Zfp423/OAZ Mutation Reveals the Importance of Olf/EBF Transcription Activity in Olfactory Neuronal Maturation
Yang A. Roby et al.
JOURNAL OF NEUROSCIENCE (2012)
The paradoxical TGF-β vasculopathies
Rosemary J. Akhurst
NATURE GENETICS (2012)
Mutations in the TGF-β repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm
Alexander J. Doyle et al.
NATURE GENETICS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Recent developments in the diagnosis of Marfan syndrome and related disorders
Kim M. Summers et al.
MEDICAL JOURNAL OF AUSTRALIA (2012)
Dual-Mode Modulation of Smad Signaling by Smad-Interacting Protein Sip1 Is Required for Myelination in the Central Nervous System
Qinjie Weng et al.
NEURON (2012)
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state
Christos Polytarchou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Novel Aptamer Targeting TGF-β Receptor II Inhibits Transdifferentiation of Human Tenon's Fibroblasts into Myofibroblast
Xiaoyan Zhu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Expression, purification, and functional characterization of recombinant PTD-SARA
Chen Huang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo
Andrea Conidi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis
Jamie McDonald et al.
GENETICS IN MEDICINE (2011)
Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth
Roselyne Castonguay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis
Ingrid M. B. H. van de laar et al.
NATURE GENETICS (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
Carla Lucia Esposito et al.
PLOS ONE (2011)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Discovery and Development of Therapeutic Aptamers
P. R. Bouchard et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Development of aptamer therapeutics
David H. J. Bunka et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Peptide ligands that use a novel binding site to target both TGF-beta receptors
Lingyin Li et al.
MOLECULAR BIOSYSTEMS (2010)
TMEPAI, a Transmembrane TGF-β-Inducible Protein, Sequesters Smad Proteins from Active Participation in TGF-β Signaling
Yukihide Watanabe et al.
MOLECULAR CELL (2010)
Development of DNA aptamers using Cell-SELEX
Kwame Sefah et al.
NATURE PROTOCOLS (2010)
The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
Francesca Di Modugno et al.
PLOS ONE (2010)
Targeting cancer cells with nucleic acid aptamers
Laura Cerchia et al.
TRENDS IN BIOTECHNOLOGY (2010)
Mowat-Wilson Syndrome: Facial Phenotype Changing With Age: Study of 19 Italian Patients and Review of the Literature
L. Garavelli et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Transforming Growth Factor type beta and Smad family signaling in stem cell function
Eve Seuntjens et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Intricacies of BMP receptor assembly
Joachim Nickel et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Applications of small molecule BMP inhibitors in physiology and disease
Charles C. Hong et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Transforming Growth Factor-beta Signaling in Thoracic Aortic Aneurysm Development: A Paradox in Pathogenesis
Jeffrey A. Jones et al.
JOURNAL OF VASCULAR RESEARCH (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Proximal events in Wnt signal transduction
Stephane Angers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
New regulatory mechanisms of TGF-β receptor function
Jong Seok Kang et al.
TRENDS IN CELL BIOLOGY (2009)
Surface-immobilized peptide aptamers as probe molecules for protein detection
Steven Johnson et al.
ANALYTICAL CHEMISTRY (2008)
A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition
Cameron P. Bracken et al.
CANCER RESEARCH (2008)
Peptide aptamers targeting mutant p53 induce apoptosis in tumor cells
Elisa Guida et al.
CANCER RESEARCH (2008)
SELEX with modified nucleotides
Anthony D. Keefe et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex
Griet Verstappen et al.
HUMAN MOLECULAR GENETICS (2008)
Cooperative assembly of TGF-β superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding
Jay Groppe et al.
MOLECULAR CELL (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
A comparative analysis of perturbations caused by a gene knock-out, a dominant negative allele, and a set of peptide aptamers
Nadia Abed et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands
Regina Stoltenburg et al.
BIOMOLECULAR ENGINEERING (2007)
miR-200b mediates post-transcriptional repression of ZFHX1B
Nanna Ronbjerg Christoffersen et al.
RNA (2007)
An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity
Benoit de Chassey et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Modulation of Nr-13 antideath activity by peptide aptamers
A-L Nouvion et al.
ONCOGENE (2007)
Ligand-regulated peptide aptamers that inhibit the 5′-AMP-activated protein kinase
Russell A. Miller et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Endofin acts as a Smad anchor for receptor activation in BMP signaling
Weibin Shi et al.
JOURNAL OF CELL SCIENCE (2007)
XSip1 neuralizing activity involves the co-repressor CtBP and occurs through BMP dependent and independent mechanisms
Leo A. van Grunsven et al.
DEVELOPMENTAL BIOLOGY (2007)
Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-β signaling
S. Kyun Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to taxol
Christian Kunz et al.
MOLECULAR CANCER RESEARCH (2006)
Inhibition of transforming growth factor-β1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA
Bryan M. Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes
Evangelia Tomai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Signaling through ERBB receptors: Multiple layers of diversity and control
CM Warren et al.
CELLULAR SIGNALLING (2006)
Selection of RNA aptamers against recombinant transforming growth factor-β type III receptor displayed on cell surface
Shoji P. Ohuchi et al.
BIOCHIMIE (2006)
δEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis
Leo A. Van Grunsven et al.
DEVELOPMENTAL DYNAMICS (2006)
Structure of the ternary signaling complex of a TGF-β superfamily member
George P. Allendorph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Peptide aptamers as guides for small-molecule drug discovery
IC Baines et al.
DRUG DISCOVERY TODAY (2006)
Current strategies for the development of peptide-based anti-cancer therapeutics
C Borghouts et al.
JOURNAL OF PEPTIDE SCIENCE (2005)
Design and validation of a neutral protein scaffold for the presentation of peptide aptamers
R Woodman et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
ET Cunningham et al.
OPHTHALMOLOGY (2005)
Selective inhibition of TGF-β responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP
QQ Cui et al.
ONCOGENE (2005)
Inhibition of the DNA binding by the TCF-1 binding RNA aptamer
MW Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase
L Cerchia et al.
PLOS BIOLOGY (2005)
An RNA aptamer that binds to the β-catenin interaction domain of TCF-1 protein
SK Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Role of HER receptors family in development and differentiation
P Casalini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
M Lepourcelet et al.
CANCER CELL (2004)
Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding
B Klevenz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Inactivation of Ras function by allele-specific peptide aptamers
CW Xu et al.
ONCOGENE (2002)
Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease
V Cacheux et al.
HUMAN MOLECULAR GENETICS (2001)
Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease
N Wakamatsu et al.
NATURE GENETICS (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways
E Labbé et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Protein transduction: unrestricted delivery into all cells?
SR Schwarze et al.
TRENDS IN CELL BIOLOGY (2000)
Molecular interactions and metal binding in the theophylline-binding core of an RNA aptamer
GR Zimmermann et al.
RNA (2000)
OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways
A Hata et al.
CELL (2000)
Structural basis of Smad2 recognition by the Smad anchor for receptor activation
G Wu et al.
SCIENCE (2000)
分享论文
